Results 221 to 230 of about 222,357 (321)

Artificial intelligence‐assisted design, synthesis and analysis of smart biomaterials

BMEMat, EarlyView.
Smart biomaterials are rapidly emerging as tools for tissue engineering, and artificial intelligence has played essential roles in biomaterial studies. By bridging the literature gap in AI‐based design, synthesis and analysis of smart biomaterials, the current review shares perspectives on how biomaterial scientists can practically incorporate AI for ...
Pengfei Jiang, Yefei Dai, Yujun Hou, Joshua Stein, Shichen Steven Lin, Chaochen Zhou, Yannan Hou, Rongrong Zhu, Ki‐Bum Lee, Letao Yang   +9 more
wiley   +1 more source

Deciphering glioblastoma pathogenesis: Insights from mitophagy dysregulation and SNX7 as a therapeutic target

Brain Research Bulletin
Background: Glioblastoma is a highly aggressive and invasive brain tumor with an extremely poor prognosis. The aims of the present study are to investigate the pathogenesis of glioblastoma and identify potential therapeutic targets. Methods: We performed
Yuanlong Zhang, Binghong Chen, Renfu Liu, Wenzhong Mei, Yuanxiang Lin   +4 more
doaj  

Multivalent Cations Depress Ligand Binding to Cell-Associated Insulin-Like Growth Factor Binding Protein-5 on Human Glioblastoma Cells* [PDF]

, 1998
Rebecca L. Sackett, Robert H. McCusker
openalex   +1 more source

Beyond the blood-brain barrier: feasibility and technical validation of dual-compartment circulating tumor cells detection in high-grade glioma patients. [PDF]

Neurosurg Rev
Juan YC, Chen X, Tseng JY, Lin HJ, Hung CH, Hsueh PR, Lin JJ, Cho DY, Chen CC.   +8 more
europepmc   +1 more source

Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas

, 1992
Kazunari Yachi, Takao Watanabe, Takashi Ohta, Takao Fukushima, Atsuo Yoshino, Akiyoshi Ogino, Yoichi Katayama, Hiroki Nagase   +7 more
openalex   +2 more sources

Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial. [PDF]

Trials
Ehinger E, Darabi A, Visse E, Edvardsson C, Tomasevic G, Cederberg D, Kinhult S, Rydelius A, Nilsson C, Belting M, Bengzon J, Siesjö P.   +11 more
europepmc   +1 more source

Comparative treatment planning: Proton vs. x-ray beams against glioblastoma multiforme

, 1992
Hideo Tatsuzaki, Marcia Urie, Rita M. Linggood   +2 more
openalex   +1 more source

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. [PDF]

, 1999
Andrey Korshunov, Andrey Golanov, Regina Sycheva, Igor Pronin   +3 more
openalex   +1 more source

Microglia and brain macrophages are differentially associated with tumor necrosis in glioblastoma: A link to tumor progression. [PDF]

Oncol Res
Loh C, Zheng Y, Alzoubi I, Alexander KL, Lee M, Cai WD, Song Y, McDonald K, Nowak AK, Banati RB, Graeber MB.   +10 more
europepmc   +1 more source

Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. [PDF]

, 1995
Erwin G. Van Meir, Klaus Roemer, Annie‐Claire Diserens, Tetsuro Kikuchi, Sandra A. Rempel, Martin Haas, Hongyi Huang, T Friedmann, Nicolas de Tribolet, Webster K. Cavenee   +9 more
openalex   +1 more source